We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
White Mountains Insurance
WTM
$5.47B
| $77.8K | ﹤0.01% |
56
-100
| -64% | -$141K |
|
802
Jack Henry & Associates
JKHY
$10.7B
| $77.1K | ﹤0.01% |
460
| – | – |
|
803
Travel + Leisure Co
TNL
$4.54B
| $76.6K | ﹤0.01% |
1,900
-1,989
| -51% | -$76.6K |
|
804
HP
HPQ
$23.5B
| $75.1K | ﹤0.01% |
2,446
+1,805
| +282% | +$54.2K |
|
805
Independent Bank
INDB
$4.05B
| $75K | ﹤0.01% |
1,684
+14
| +0.8% | +$726 |
|
806
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
| $73.9K | ﹤0.01% |
997
| – | – |
|
807
Weyerhaeuser
WY
$17.3B
| $73.8K | ﹤0.01% |
+2,201
| New | +$66.3K |
|
808
Tactile Systems Technology
TCMD
$620M
| $72.4K | ﹤0.01% |
2,906
| – | – |
|
809
Western Union
WU
$2.57B
| $72.4K | ﹤0.01% |
6,175
| – | – |
|
810
Occidental Petroleum Corp Warrants
OXY.WS
$33.2B
| $71.6K | ﹤0.01% |
1,918
+22
| +1% | +$841 |
|
811
ICU Medical
ICUI
$3.93B
| $71.3K | ﹤0.01% |
400
| – | – |
|
812
Tapestry
TPR
$28.8B
| $70.3K | ﹤0.01% |
1,642
| – | – |
|
813
Workday
WDAY
$33.4B
| $70.3K | ﹤0.01% |
311
+131
| +73% | +$26.2K |
|
|
BBU
814
DELISTED
Brookfield Business Partners
BBU
| $69.4K | ﹤0.01% |
4,027
-3,977
| -50% | -$72.7K |
|
815
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
| $69.3K | ﹤0.01% |
2,056
+213
| +12% | +$6.95K |
|
816
Yeti Holdings
YETI
$3.82B
| $68.9K | ﹤0.01% |
1,775
| – | – |
|
817
iShares Biotechnology ETF
IBB
$9.31B
| $68.6K | ﹤0.01% |
540
| – | – |
|
818
Atlassian
TEAM
$22B
| $68.5K | ﹤0.01% |
408
| – | – |
|
819
Zoom
ZM
$25.8B
| $68.4K | ﹤0.01% |
1,007
+73
| +8% | +$4.88K |
|
|
DISH
820
DELISTED
DISH Network Corp.
DISH
| $68.3K | ﹤0.01% |
2,000
-1,605
| -45% | -$11.4K |
|
821
Sanara MedTech
SMTI
$234M
| $68.2K | ﹤0.01% |
1,700
| – | – |
|
822
Lumen
LUMN
$6.53B
| $67.9K | ﹤0.01% |
30,024
-1,284
| -4% | -$2.83K |
|
823
Digital Realty Trust
DLR
$73.7B
| $67.3K | ﹤0.01% |
591
-17,708
| -97% | -$1.75M |
|
824
Indivior Pharmaceuticals
INDV
$4.79B
| $66.5K | ﹤0.01% |
+2,795
| New | +$64.1K |
|
825
British American Tobacco
BTI
$132B
| $66.4K | ﹤0.01% |
2,000
-2,150
| -52% | -$73.5K |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.